Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CHRND - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GSK3A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MPP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HCFC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
CACTIN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KRT17 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
TEF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNF212 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC102723697 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STOML3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAGEB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TPPP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NKX2-5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR133A1HG - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMYD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADGRA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRRC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on